Related Articles Hedge Funds Hope to Cash In on Perceptive Advisors’ SPAC Stephen Taub Biopharma Funds Deliver Market-Beating Returns as Valuations Snap Back Stephen Taub Outlook 2026: Take an Active Approach to Valuation Risk and Seek Opportunities to Diversify Sponsored by Schroders